 |
Julius M. Wilder, MD, PhD Assistant Professor of Medicine Department of Gastroenterology Duke University School of Medicine Durham, North Carolina |
Target Audience
This activity is intended for physicians, physician assistants, advanced practice nurses, general practitioners and other health care professionals involved in the treatment and management of patients who have or are at risk of HCV infection.
Learning Objectives
Upon completion of theactivity, participants should be better able to:
Joint Accreditation Statement:
Insupport of improving patient care, this activity has been planned andimplemented by the Postgraduate Institute for Medicine and ViralEd, Inc.Postgraduate Institute for Medicine is jointly accredited by the AccreditationCouncil for Continuing Medical Education (ACCME), the Accreditation Council forPharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC),to provide continuing education for the healthcare team.
ThePostgraduate Institute for Medicine designates this live activity for a maximumof 1.0 AMA PRA Category 1 Credit(s)™. Physiciansshould claim only the credit commensurate with the extent of theirparticipation in the activity.
A statement of credit will beissued only upon receipt of a completed activity evaluation form and will be emailedto you.
Disclosure of Conflicts ofInterest
PostgraduateInstitute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity todisclose any real or apparent conflict of interest (COI) they may have asrelated to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy.
PIM is committed to providing its learners with high quality CMEactivities and related materials that promote improvements or quality in healthcareand not a specific proprietary business interest of a commercial interest.
The faculty reported the following financialrelationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity:
Julius Wilder, MD, PhD
Disclosure of Unlabeled Use
This educationalactivity may contain discussion of published and/or investigational uses ofagents that are not indicated by the FDA. The planners of this activity do notrecommend the use of any agent outside of the labeled indications.
The opinions expressedin the educational activity are those of the faculty and do not necessarilyrepresent the views of the planners. Please refer to the official prescribing information for each productfor discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have animplied responsibility to use the newly acquired information to enhance patientoutcomes and their own professional development. The information presented inthis activity is not meant to serve as a guideline for patient management. Anyprocedures, medications, or other courses of diagnosis or treatment discussedor suggested in this activity should not be used by clinicians withoutevaluation of their patient’s conditions and possible contraindications and/ordangers in use, review of any applicable manufacturer’s product information,and comparison with recommendations of other authorities.
